Loading...
Compassionate use of ruxolitinib in patients with SARS‐Cov‐2 infection not on mechanical ventilation: Short‐term effects on inflammation and ventilation
ABSTRACT: Ruxolitinib is an anti‐inflammatory drug that inhibits the Janus kinase‐signal transducer (JAK‐STAT) pathway on the surface of immune cells. The potential targeting of this pathway using JAK inhibitors is a promising approach in patients affected by coronavirus disease 2019 (COVID‐19). Rux...
Na minha lista:
| Udgivet i: | Clin Transl Sci |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8212747/ https://ncbi.nlm.nih.gov/pubmed/33403775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12971 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|